EAST HANOVER, N.J., May 27, 2026 /PRNewswire/ -- Increasing demand for estrogen therapy coupled with a growing awareness and interest in the menopause market have led to supply disruptions with the ...
June 8, 2005 — The U.S. Food and Drug Administration (FDA) approved in March revisions to safety labeling to advise that use of rosuvastatin calcium tablets is associated with an increased risk of ...
* CARLYLE - CO, JOHN KING, ROGER BOISSONNEAULT, GEOFFREY ELLIOTT JOINTLY LAUNCH MILLICENT PHARMA; FEMRING ACQUIRED FROM ALLERGAN BY MILLICENT * CARLYLE GROUP - KING WILL SERVE AS CHAIRMAN OF MILLICENT ...
With ongoing shortages impacting estrogen therapy patches, Femring offers consistent access and a dual indication for women navigating multiple symptoms of menopause. EAST HANOVER, N.J., May 27, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results